Skip to main content
. 2023 Aug 4;46(11):1310–1318. doi: 10.1002/clc.24110

Table 2.

Clinical characteristics of patients with intraoperative conversion from mitral valve repair to replacement.

Variable Intraoperative conversion p‐Value
With (n = 75) Without (n = 225)
Clinical characteristics
Age (mean ± SD, years) 59.6 ± 9.94 59.4 ± 8.72 .296
Female, n (%) 44 (58.7) 87 (38.7) .002
BMI (kg/m2) 23.9 ± 3.86 24.1 ± 3.44 .590
Hypertension, n (%) 38 (50.7) 130 (57.8) .283
Diabetes mellitus, n (%) 8 (10.7) 14 (6.2) .201
Smoking, n (%) 18 (24) 61 (27.1) .596
Alcohol, n (%) 14 (18.7) 61 (27.1) .144
Prior stroke/TIA history, n (%) 4 (5.3) 11 (4.9) 1.000
Coronary heart disease, n (%) 20 (26.7) 62 (27.6) .881
Paroxysmal or chronic AF, n (%) 22 (29.3) 28 (12.4) .001
Conduction system disease, n (%) 7 (9.3) 11 (4.9) .261
NT‐ProBNP (pg/mL, median [IQR]) 936.5 (423.5–1827) 547 (174–1497.5) .008
MAC present on CT, n (%) 49 (65.3) 31 (13.8) <.001
MAC score 324.3 ± 889.1 183.5 ± 957.8 .003
AVC present on CT, n (%) 29 (38.7) 68 (30.2) .176
Echocardiography on admission
LADD (mm, median [IQR]) 48 (45–56) 40 (37–43) .001
LVEDV (mL) 127.5 ± 52.7 145.4 ± 56.1 .016
LVESV (mL) 57.2 ± 28.9 63.7 ± 31.4 .117
LVEF (%) 55.8 ± 5.04 56.7 ± 5.40 .237
Aortic stenosis, n (%) 21 (28) 35 (15.6) .017
Aortic regurgitation, n (%) 27 (36) 64 (28.4) .218
Mitral stenosis, n (%) 35 (46.7) 38 (16.9) <.001
Mitral regurgitation, n (%) 75 (100) 225 (100)
Tricuspid regurgitation, n (%) 55 (73.3) 131 (58.2) .020

Abbreviations: AF, atrial fibrillation; AVC, aortic valve calcification; BMI, body mass index; IQR, interquartile range; LADD, left atrial end‐diastolic dimension; LVEDV/LVESV, left ventricular end‐diastolic/end‐systolic volume; LVEF, left ventricle ejection fraction; MAC, mitral annular calcification; n, number; NYHA, New York Heart Association; SD, standard deviation; TIA, transient ischemic attack.